The process begins with the extraction of RNA from a sample of T-cells. This RNA is then reverse-transcribed into complementary DNA (cDNA), which is used as the template for polymerase chain reaction (PCR) amplification. The amplified products are then sequenced using next-generation sequencing (NGS) technologies, allowing for the identification of the diverse range of TCRs present.
